PierianDx Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
320
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
8
- Investments
-
1
PierianDx General Information
Description
Developer of a cloud-based clinical software designed to facilitate research on the sequencing testing process. The company's software uses artificial intelligence to automate the process of taking DNA sequencing data through analysis, interpretation and final report, thereby empowering physicians in the laboratory and clinic to effectively diagnose and treat patients with cancer and other complex diseases.
Contact Information
Website
www.pieriandx.com(Operating Subsidiary)
Corporate Office
- 6 Cityplace Drive
- Suite 550
- Creve Coeur, MO 63141
- United States
Corporate Office
- 6 Cityplace Drive
- Suite 550
- Creve Coeur, MO 63141
- United States
PierianDx Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
PierianDx Comparisons
Industry
Financing
Details
PierianDx Competitors (22)
One of PierianDx’s 22 competitors is Genalice, a Formerly PE-Backed company based in Harderwijk, Netherlands.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genalice | Formerly PE-Backed | Harderwijk, Netherlands | ||||
| Tempus AI | Formerly VC-backed | Chicago, IL | ||||
| Fabric Genomics | Formerly VC-backed | Oakland, CA | ||||
| Genoox | Formerly PE-Backed | Palo Alto, CA | ||||
| InterpretOmics | Formerly VC-backed | Bangalore, India |
PierianDx Patents
PierianDx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20150066378-A1 | Identifying possible disease-causing genetic variants by machine learning classification | Inactive | 27-Aug-2013 |
PierianDx Signals
PierianDx Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
PierianDx Acquisitions (1)
PierianDx’s most recent deal was a Merger/Acquisition with Tute Genomics. The deal was made on 12-Oct-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Tute Genomics | 12-Oct-2016 | Merger/Acquisition | Social/Platform Software |
PierianDx FAQs
-
When was PierianDx founded?
PierianDx was founded in 2014.
-
Where is PierianDx headquartered?
PierianDx is headquartered in Creve Coeur, MO.
-
What is the size of PierianDx?
PierianDx has 320 total employees.
-
What industry is PierianDx in?
PierianDx’s primary industry is Decision/Risk Analysis.
-
Is PierianDx a private or public company?
PierianDx is a Private company.
-
What is PierianDx’s current revenue?
The current revenue for PierianDx is .
-
How much funding has PierianDx raised over time?
PierianDx has raised $116M.
-
Who are PierianDx’s investors?
ARUP Laboratories, ATW Partners, Album VC, Bodhi Capital, and Health Catalyst Capital Management are 5 of 15 investors who have invested in PierianDx.
-
Who are PierianDx’s competitors?
Genalice, Tempus AI, Fabric Genomics, Genoox, and InterpretOmics are some of the 22 competitors of PierianDx.
-
When was PierianDx acquired?
PierianDx was acquired on 01-Apr-2025.
-
Who acquired PierianDx?
PierianDx was acquired by Velsera.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process